GB201217892D0 - Treatment of cancer - Google Patents

Treatment of cancer

Info

Publication number
GB201217892D0
GB201217892D0 GBGB1217892.7A GB201217892A GB201217892D0 GB 201217892 D0 GB201217892 D0 GB 201217892D0 GB 201217892 A GB201217892 A GB 201217892A GB 201217892 D0 GB201217892 D0 GB 201217892D0
Authority
GB
United Kingdom
Prior art keywords
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1217892.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virttu Biologics Ltd
Original Assignee
Virttu Biologics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virttu Biologics Ltd filed Critical Virttu Biologics Ltd
Priority to GBGB1217892.7A priority Critical patent/GB201217892D0/en
Publication of GB201217892D0 publication Critical patent/GB201217892D0/en
Priority to PCT/GB2013/052593 priority patent/WO2014053852A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/763—Herpes virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
GBGB1217892.7A 2012-10-05 2012-10-05 Treatment of cancer Ceased GB201217892D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1217892.7A GB201217892D0 (en) 2012-10-05 2012-10-05 Treatment of cancer
PCT/GB2013/052593 WO2014053852A1 (en) 2012-10-05 2013-10-04 Treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1217892.7A GB201217892D0 (en) 2012-10-05 2012-10-05 Treatment of cancer

Publications (1)

Publication Number Publication Date
GB201217892D0 true GB201217892D0 (en) 2012-11-21

Family

ID=47294346

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1217892.7A Ceased GB201217892D0 (en) 2012-10-05 2012-10-05 Treatment of cancer

Country Status (2)

Country Link
GB (1) GB201217892D0 (en)
WO (1) WO2014053852A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3199181B1 (en) * 2014-09-22 2020-05-06 Japan Science and Technology Agency Anti-influenza virus agent, and screening method for anti-influenza virus agent
WO2016201265A1 (en) * 2015-06-12 2016-12-15 Mayo Foundation For Medical Education And Research Mumps virus as a potential oncolytic agent
ES2923782T3 (en) 2015-12-02 2022-09-30 Memorial Sloan Kettering Cancer Center Oncotherapy directed at the Seneca Valley virus (SVV) cell receptor
AU2019275404A1 (en) 2018-05-21 2020-12-03 Nanostring Technologies, Inc. Molecular gene signatures and methods of using same
CN108530337B (en) * 2018-06-25 2020-11-03 南华大学 Indoleamide compound capable of selectively inhibiting gastric cancer cells
CA3136671A1 (en) * 2019-04-11 2020-10-15 Seneca Therapeutics, Inc. Compositions and methods of using seneca valley virus (svv) for treating cancer
US20230075368A1 (en) * 2020-02-19 2023-03-09 The United States Govemment as represented by the Department of Veterans Affairs Identification of an egfr-bin3 pathway that actively suppresses invasion and reduces tumor size in glioblastoma

Also Published As

Publication number Publication date
WO2014053852A1 (en) 2014-04-10

Similar Documents

Publication Publication Date Title
IL288181A (en) Methods of treating cancer
HK1202253A1 (en) Combination treatment of cancer
HK1211982A1 (en) Cancer treatment
HK1214128A1 (en) Treatment of cancer
HK1205254A1 (en) Methods of treatment of cancer
IL228430A0 (en) Treatment of cancer
GB201217892D0 (en) Treatment of cancer
HK1204956A1 (en) Treatment of cancer
HK1210023A1 (en) Cancer treatment
SI2892925T1 (en) Combination treatment of cancer
PL2855475T3 (en) Alpha-carbolines for the treatment of cancer
GB201217890D0 (en) Treatment of cancer
GB201222563D0 (en) Cancer treatment
GB201208296D0 (en) Treatment of cancer
GB201222949D0 (en) Combination Treatment of Cancer
GB201222950D0 (en) Combination treatment of cancer
GB201121791D0 (en) Combination treatment of cancer
GB201121783D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)